Hyperbaric Oxygen (2.0 ATA Hard Chamber) Studio Solver
Underwrite clinical longevity centers deploying 2.0 ATA hard-shell monoplace hyperbaric oxygen chambers supersaturating blood plasma with dissolved oxygen to stimulate angiogenesis.
Chambers & Daily Sessions
Annual Studio Financials
Annual Gross Hyperbaric Oxygen Billings
$1,401,600 / yr
Net Operating Income (EBITDA)
+$1,124,400 / yr (80.2% Margin)
Hardware Capital Payback Period
2.0 Months Payback (608% ROI)